Interactive Q&A on key M&A issues in Healthcare and Life Sciences

As the National Healthcare & Life Sciences Industry Leader of Deloitte’s M&A Transaction Services, Philip E. Pfrang has advised clients on more than 400 completed and proposed transactions and has extensive experience in cross–border and multinational deals.

Directorship spoke with Pfrang about trends in the healthcare and life sciences marketplace and his prognostications for M&A in the near term. You will find excerpts from this interview and we invite you to comment on key M&A issues facing healthcare and life sciences and offer your input. If you so choose, you can contact Pfrang directly within this survey.

Click here to link to this brief survey

Click here to download the complete interview